Skip to main content

Gal Munda

Stock Analyst at Wolfe Research

Total Price Targets
8
Stocks Covered
6
Sectors
Healthcare, Technology
Most Recent
Feb 26, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • CDNS+9.6%
    Cadence Design Systems, Inc.
    $385.00 targetOct 28, 2025
  • AI-26.3%
    C3.ai, Inc.
    $6.00 targetFeb 26, 2026

Most Bearish

  • AI-26.3%
    C3.ai, Inc.
    $6.00 targetFeb 26, 2026
  • CDNS+9.6%
    Cadence Design Systems, Inc.
    $385.00 targetOct 28, 2025

Stocks Covered by Gal Munda

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
AIC3.ai, Inc.$6.00$9.20-34.7%1Feb 26, 2026
CDNSCadence Design Systems, Inc.$385.00$340.82+13.0%2Oct 28, 2025
ADSKAutodesk, Inc.$270.00$246.19+9.7%2Aug 17, 2022
APPAppLovin Corporation$40.00$460.62-91.3%1Aug 16, 2022
UUnity Software Inc.$145.00$27.15+434.1%1Aug 11, 2021
PHRPhreesia, Inc.$70.00$9.68+623.1%1Jun 8, 2021

Recent Activity

  • Feb 26, 2026— Set$6.00price target onAI(C3.ai, Inc.)
  • Oct 28, 2025— Set$385.00price target onCDNS(Cadence Design Systems, Inc.)
  • Aug 17, 2022— Set$270.00price target onADSK(Autodesk, Inc.)
  • Aug 16, 2022— Set$40.00price target onAPP(AppLovin Corporation)
  • Feb 23, 2022— Set$180.00price target onCDNS(Cadence Design Systems, Inc.)
  • Nov 17, 2021— Set$400.00price target onADSK(Autodesk, Inc.)
  • Aug 11, 2021— Set$145.00price target onU(Unity Software Inc.)
  • Jun 8, 2021— Set$70.00price target onPHR(Phreesia, Inc.)

Frequently Asked Questions

Who is Gal Munda?

Gal Munda is a stock analyst at Wolfe Research covering 6 stocks primarily in Healthcare, Technology. They have issued 8 price targets since Jun 8, 2021.

What stocks does Gal Munda cover?

Gal Munda currently covers 6 stocks, including CDNS, ADSK, AI, APP, U.

What is Gal Munda's latest price target?

Gal Munda's most recent price target was $6.00 on AI (C3.ai, Inc.), set on Feb 26, 2026.

What is Gal Munda's highest price target?

Gal Munda's highest issued price target is $400.00 on ADSK, set on Nov 17, 2021.

Coverage based on publicly published price targets. Not investment advice.